Fig. 5 | npj Vaccines

Fig. 5

From: Safety and efficacy of novel malaria vaccine regimens of RTS,S/AS01B alone, or with concomitant ChAd63-MVA-vectored vaccines expressing ME-TRAP

Fig. 5

a CSP-specific IgG titers and TRAP-specific ELISPOT responses at C-1, stratified by vaccine regime and CHMI outcome. CSP-specific IgG titers (left y-axis) and TRAP-specific ELISPOT responses (right y-axis) at C-1, stratified by vaccine regime and CHMI outcome. **P = 0.009, two-tailed Mann–Whitney test. VV, viral vectors. Bars represent medians with IQR. b ELISPOT responses and ELISA titers for each individual participant with protection status after CHMI indicated. Circles indicate participants sterilely protected after CHMI and triangles non-protected participants

Back to article page